Navitoclax-impurities | Pharmaffiliates

navitoclax

Navitoclax is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies, among others. Reference standards of Navitoclax API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Navitoclax - API
    [catalogue_number] => PA 14 82000
    [category_ids] => ,69,81,78,70,82,88,
    [chemical_name] => 
    [weight] => 974.61
    [form] => C47H55ClF3N5O6S3
    [cas] => 923564-51-6
    [pslug] => 923564-51-6-navitoclax-api-pa1482000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 14 82000

Navitoclax - API


  • Catalogue No.:PA 14 82000

  • CAS :

    923564-51-6

  • Molecular Formula : C47H55ClF3N5O6S3

  • Molecular Weight : 974.61